NCT00722865View on ClinicalTrials.gov

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Hodgkin Lymphoma
Interventions
DRUG

Avastin

Given intravenously along with standard chemotherapy (Adriamycin, Bleomycin, Vinblastine and Dacarbazine) on days 1 and 15 of a 28-day cycle for a total of 6 planned cycles.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER